Zai Lab Ltd (ZLAB.US) - The Strength and the Concerns
This insight analyzes Zai Lab about its distinctive pipeline, the management team, the concerns on license-in mode, regulatory...
266 Views
Alphamab Co Ltd (9966.HK) - Some Points Worth the Attention
The article analyzed Alphamab Oncology in terms of its conservativeness on business operation and decision making in early stages, the concerns on...
238 Views
Shanghai Junshi Bioscience (1877.HK) - Will Junshi Progress or Go Backwards Instead?
The article mainly analyzed Junshi in terms of the pipeline, commercialization strategy, the talents, the outlook, the related concerns, as well as...
248 Views
MicroPort MedBot Pre-IPO - Thoughts on Valuation
MicroPort MedBot (MM), a surgical robot company, aims to raise up to US$1bn in its Hong Kong IPO. It is a subsidiary of Microport Scientific (853...
359 Views
Kintor Pharmaceutical (9939 HK) – Dual Play on COVID and Solid Tumors
Kintor Pharma is set to fly high ahead of its first product launch in China for prostate cancer, which has high unmet medical need. COVID-19...
349 Views